Morilak Lab Receives CPRIT Grant To Study Cognitive Impairment
The Cancer Prevention & Research Institute of Texas has awarded David Morilak, Ph.D., from UT Health San Antonio, a research award of $899,547. The funds will be used to study mechanisms and new treatments for cognitive impairment associated with a type of hormone treatment used in men with prostate cancer.
Dr. Morilak is a professor in the Department of Pharmacology, director of UT Health San Antonio’s Center for Biomedical Neuroscience and a member of the Mays Cancer Center, the newly named center of the UT Health San Antonio MD Anderson Cancer Center.
Read Full Article
Leave a Reply